Hostname: page-component-cd9895bd7-jkksz Total loading time: 0 Render date: 2024-12-26T01:48:01.852Z Has data issue: false hasContentIssue false

Use of antipsychotic depot medication in the elderly in UK

Published online by Cambridge University Press:  16 April 2020

J. Caballer
Affiliation:
Servicios de Salud Mental del Principado de Asturias, Centro de Salud Mental I, Area V de Gijon, Asturias, Spain
J. Ferran
Affiliation:
Department of Psychiatry, Clatterbridge Hospital, Bebington, United Kingdom

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background:

The use of antipsychotic depot medication in old age needs to be reviewed for knowing the adequacy on its prescription in this part of the population. The patterns of depot medication use in an area of England are presented.

Aims and objectives

Know patient's sociodemographic characteristics, type of diagnoses, care status, and type of depot medication.

Review if depot medication is prescribed between the recommended frequencies and doses.

Value the suitability of depot treatments in these patients.

Value the follow up, included recommended investigations.

Methods:

Retrospective and descriptive study over a Sample of 23 patients on depot medication (Age >64 years old).

Sociodemographic, clinical, care, suitability, follow up and monitoring variables are collected.

The results are analyzed in accordance with the NICE guidelines recommendations.

Results:

The profile of an old patient receiving depot medication is a woman, about 73 years old, single, living in a residential home or alone and with a diagnoses of schizophrenia (30 years on illness).

The 2 most prescribed medications were Zuclopentixol and Fluphenazine.

The majority of patients didn't relapse with depot medication.

Conclusions:

Tthe patients have been seen by the community team between the recommended intervals; depot medications have been given between the recommended limits of frequency and range of dose.

In an important proportion of patients it's unknown the time on depot and which other oral medications have been tried.

About the follow up of the patients, The recommended monitoring hasn't been followed or it hasn't been recorded in the case notes.

Type
Poster Session 2: Psychogeriatrics
Copyright
Copyright © European Psychiatric Association 2007
Submit a response

Comments

No Comments have been published for this article.